Novo Holdings, Catalent Reset Review Clock On $16.5B Deal
By Matthew Perlman · April 4, 2024, 6:10 PM EDT
Novo Nordisk Foundation has given the Federal Trade Commission more time for an initial review of Novo Holdings' plan to acquire Catalent in a deal that values the pharmaceutical services company...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login